Detection of prostate specific antigen messenger RNA from pelvic lymph node in prostate cancer - Its role in the diagnosis and staging of prostate cancer

By Hoshi S.   Orikasa S.   Takahashi T.   Kaneda T.   Mao H.   Ohkawa A.   Funatob T.   Kimura N.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 5, 1997-09 ,pp. : 183-188

Elsevier

Access to resources Recommend Favorite

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy

By                    

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 819-824

Spandidos Publications

Access to resources Recommend Favorite

The role of radical prostatectomy in patients with pretreatment prostate-specific antigen >=40 ng/mL*

By Vanasupa B.P.   Paquette E.L.   Wu H.   Sun L.   McLeod D.G.   Moul J.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 4, 2002-07 ,pp. : 167-172

Elsevier

Access to resources Recommend Favorite

Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

By May Matthias  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 2018-2025

Springer Publishing Company

Access to resources Recommend Favorite

Accuracy of frozen section examination of pelvic lymph nodes in patients with FIGO stage IB1 to IIB cervical cancer

By Scholz H.S.   Lax S.F.   Benedicic C.   Tamussino K.   Winter R.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 605-609

Elsevier

Access to resources Recommend Favorite